30 Day Trial

ORTHOKNOW content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Quarterly Review

1Q14 Revenue: Globus Medical

$114.2MM, +9% (U.S. $101.7MM, +6%; ex-U.S. $12.5MM, +43%)

  • Innovative Fusion $66.8MM, +9%
  • Disruptive Technology $47.4MM, +9%


  • Growth impacted by severe U.S .weather
  • Price pressure remains in low- to mid-single digits
  • Excelsius (robotics) team fully integrated
  • Pleased with KINEX feedback
  • Launched REVERE Threaded for complex deformity and MONUMENT anterior lumbar interbody spacer (latter in 2Q)
  • 2014 launches include CREO threaded, cortical and MIS (CREO should be largest product line by 2016)
  • Expecting no large impact from spine portion of Zimmer + Biomet transaction